Stumbled across an update on the 008 trial.........
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381039
Key points:
- last patient enrolment expected 25/3/22 (just over 5 weeks away). I like the sound of that given a 56 day primary endpoint and topline soon after.
- addition of NSW centre. Novatrials if anyone is interested...https://www.novatrials.com.au/current-trials#currently-enrolling
Oh, and while on the ANZCTR site, a recent update on MPS1.........
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379536
Of note is expected recruitment of last patient on 30/6/22 (this too sounds good to me given we are currently sitting at only 3 of the 10 recruited)
research reports and media, page-2383
-
- There are more pages in this discussion • 2,046 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $85.35K | 365.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 280011 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 44703 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |